Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$5.08 - $9.81 $359,735 - $694,685
-70,814 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$8.55 - $111.89 $61,978 - $811,090
-7,249 Reduced 9.29%
70,814 $693,000
Q3 2021

Nov 10, 2021

BUY
$76.53 - $110.43 $187,421 - $270,443
2,449 Added 3.24%
78,063 $8.27 Million
Q2 2021

Aug 13, 2021

BUY
$85.37 - $114.1 $872,908 - $1.17 Million
10,225 Added 15.64%
75,614 $6.46 Million
Q1 2021

May 14, 2021

BUY
$109.73 - $153.66 $534,714 - $748,785
4,873 Added 8.05%
65,389 $7.51 Million
Q4 2020

Feb 02, 2021

BUY
$79.58 - $152.45 $423,445 - $811,186
5,321 Added 9.64%
60,516 $8.47 Million
Q3 2020

Nov 05, 2020

BUY
$66.43 - $90.99 $86,359 - $118,287
1,300 Added 2.41%
55,195 $4.5 Million
Q2 2020

Aug 12, 2020

BUY
$44.04 - $80.69 $463,168 - $848,616
10,517 Added 24.25%
53,895 $3.87 Million
Q1 2020

May 12, 2020

BUY
$44.49 - $93.39 $443,921 - $931,845
9,978 Added 29.87%
43,378 $1.93 Million
Q4 2019

Jan 27, 2020

BUY
$66.49 - $137.73 $1.61 Million - $3.34 Million
24,235 Added 264.43%
33,400 $3.19 Million
Q3 2019

Oct 31, 2019

BUY
$31.0 - $89.73 $131,843 - $381,621
4,253 Added 86.58%
9,165 $721,000
Q2 2019

Aug 15, 2019

BUY
$36.0 - $44.73 $176,832 - $219,713
4,912 New
4,912 $213,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $22M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.